Approval · Notice of Compliance 155 · 2003
SERC: Notice of Compliance 155
Issued September 5, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 155
- Date
- September 5, 2003
- Company
- Solvay Pharma Inc.Saint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New strength: tablet 24 mg
- Therapeutic class
- Anti-vertigo agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SERC | 02247998 | Marketed |
Medicinal ingredients
- BETAHISTINE HYDROCHLORIDE 24 MG per TAB